Relmada Therapeutics, Inc. (RLMD) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Relmada Therapeutics, Inc. (RLMD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $549.3M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 0.43 to the broader market. Relmada Therapeutics, Inc. Led by Sergio Traversa, public since 2014-06-20.
Snapshot as of May 15, 2026.
- Spot Price
- $6.97
- Total OI
- 9.5K